Roivant Sciences Ltd to Announce Positive Results From the Induction Period of the TUSCANY-2 Call Transcript
Good day, and thank you for standing by. Welcome to the Roivant Sciences Investor Call. (Operator Instructions) Please be advised that today's conference is being recorded.
I would now like to hand the conference over to your speaker today, Stephanie Lee. Please go ahead.
Good morning, and thank you for joining today's call to discuss RVT-3101 Phase 2b data. I'm Stephanie Lee with Roivant. Presenting today, we've got Matt Gline, Chief Executive Officer of Roivant; and Mayukh Sukhatme, President and Chief Investment Officer of Roivant.
For those dialing in via conference call, you can find the slides being presented today as well as the press release announcing these updates on our IR website at www.investors.roivant.com. We'll also be providing the current slide numbers as we present to help you follow along.
I'd like to remind you that we'll be making certain forward-looking statements today during today's
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |